146 related articles for article (PubMed ID: 9607798)
1. Differential metabolite accumulation may be the cause of strain differences in sensitivity to streptozotocin-induced beta cell death in inbred mice.
Cardinal JW; Allan DJ; Cameron DP
Endocrinology; 1998 Jun; 139(6):2885-91. PubMed ID: 9607798
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose)polymerase activation determines strain sensitivity to streptozotocin-induced beta cell death in inbred mice.
Cardinal JW; Allan DJ; Cameron DP
J Mol Endocrinol; 1999 Feb; 22(1):65-70. PubMed ID: 9924181
[TBL] [Abstract][Full Text] [Related]
3. KATP channel-deficient pancreatic beta-cells are streptozotocin resistant because of lower GLUT2 activity.
Xu J; Zhang L; Chou A; Allaby T; Bélanger G; Radziuk J; Jasmin BJ; Miki T; Seino S; Renaud JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E326-35. PubMed ID: 18042662
[TBL] [Abstract][Full Text] [Related]
4. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
[TBL] [Abstract][Full Text] [Related]
5. Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin.
Hosokawa M; Dolci W; Thorens B
Biochem Biophys Res Commun; 2001 Dec; 289(5):1114-7. PubMed ID: 11741307
[TBL] [Abstract][Full Text] [Related]
6. [Establishment and application of the model of islet impaired by NO free radical released from streptozotocin].
Qian FY; Ouyang F; Fu DX; Ren TR
Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):349-52. PubMed ID: 15969020
[TBL] [Abstract][Full Text] [Related]
7. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
8. Destruction of pancreatic beta cells in rats by complete Freund's adjuvant combined with non-diabetogenic doses of streptozotocin.
Kohnert KD; Odselius R; Fält K; Ziegler B; Ziegler M; Falkmer S
Diabetes Res; 1987 May; 5(1):1-11. PubMed ID: 2957141
[TBL] [Abstract][Full Text] [Related]
9. Melatonin protects against streptozotocin, but not interleukin-1beta-induced damage of rodent pancreatic beta-cells.
Andersson AK; Sandler S
J Pineal Res; 2001 Apr; 30(3):157-65. PubMed ID: 11316326
[TBL] [Abstract][Full Text] [Related]
10. Glucose transporter 2 expression: prevention of streptozotocin-induced reduction in beta-cells with 5-thio-D-glucose.
Wang Z; Gleichmann H
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():83-97. PubMed ID: 8839260
[TBL] [Abstract][Full Text] [Related]
11. Acute exposure to streptozotocin but not human proinflammatory cytokines impairs neonatal porcine islet insulin secretion in vitro but not in vivo.
Harb G; Toreson J; Dufour J; Korbutt G
Xenotransplantation; 2007 Nov; 14(6):580-90. PubMed ID: 17991146
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin.
Müller A; Schott-Ohly P; Dohle C; Gleichmann H
Immunobiology; 2002 Mar; 205(1):35-50. PubMed ID: 11999343
[TBL] [Abstract][Full Text] [Related]
13. In vitro response to interleukin-1 beta and streptozotocin in pancreatic islets isolated from male and female nonobese diabetic mice.
Strandell E; Sandler S
J Endocrinol; 1997 Apr; 153(1):81-6. PubMed ID: 9135572
[TBL] [Abstract][Full Text] [Related]
14. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
Herold KC; Baumann E; Vezys V; Buckingham F
J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mice expressing IFN-gamma in pancreatic beta-cells are resistant to streptozotocin-induced diabetes.
Gu D; Arnush M; Sawyer SP; Sarvetnick N
Am J Physiol; 1995 Dec; 269(6 Pt 1):E1089-94. PubMed ID: 8572201
[TBL] [Abstract][Full Text] [Related]
16. Progressive damage of cultured pancreatic islets after single early exposure to streptozocin.
Bolaffi JL; Nowlain RE; Cruz L; Grodsky GM
Diabetes; 1986 Sep; 35(9):1027-33. PubMed ID: 2943617
[TBL] [Abstract][Full Text] [Related]
17. Novel role of curcumin in the prevention of cytokine-induced islet death in vitro and diabetogenesis in vivo.
Kanitkar M; Gokhale K; Galande S; Bhonde RR
Br J Pharmacol; 2008 Nov; 155(5):702-13. PubMed ID: 18695642
[TBL] [Abstract][Full Text] [Related]
18. Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets.
Turk J; Corbett JA; Ramanadham S; Bohrer A; McDaniel ML
Biochem Biophys Res Commun; 1993 Dec; 197(3):1458-64. PubMed ID: 7904159
[TBL] [Abstract][Full Text] [Related]
19. Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.
Anderson T; Schein PS; McMenamin MG; Cooney DA
J Clin Invest; 1974 Sep; 54(3):672-7. PubMed ID: 4369217
[TBL] [Abstract][Full Text] [Related]
20. Human beta cells are exceedingly resistant to streptozotocin in vivo.
Yang H; Wright JR
Endocrinology; 2002 Jul; 143(7):2491-5. PubMed ID: 12072379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
